Assura (AGR) Stock Rating Reaffirmed by Jefferies Group

Assura (LON:AGR)‘s stock had its “buy” rating reiterated by stock analysts at Jefferies Group in a research note issued on Thursday. They presently have a GBX 70 ($0.95) price target on the real estate investment trust’s stock. Jefferies Group’s price objective would indicate a potential upside of 14.75% from the stock’s previous close.

Several other equities analysts have also weighed in on the stock. Peel Hunt raised their price objective on shares of Assura from GBX 55 ($0.75) to GBX 57 ($0.77) and gave the company a “hold” rating in a research report on Thursday, November 16th. Liberum Capital restated a “buy” rating and set a GBX 68 ($0.92) price objective on shares of Assura in a research report on Thursday, November 16th.

Assura (LON AGR) traded down GBX 0.10 ($0.00) during trading hours on Thursday, hitting GBX 61 ($0.83). 2,440,000 shares of the stock traded hands, compared to its average volume of 2,910,000. Assura has a one year low of GBX 51.35 ($0.70) and a one year high of GBX 67.30 ($0.91). The company has a market cap of $1,450.00 and a price-to-earnings ratio of 871.43.

In other Assura news, insider Jonathan Murphy acquired 70,175 shares of Assura stock in a transaction dated Thursday, November 16th. The stock was bought at an average price of GBX 57 ($0.77) per share, for a total transaction of £39,999.75 ($54,244.30).

TRADEMARK VIOLATION NOTICE: This report was originally reported by American Banking News and is the sole property of of American Banking News. If you are reading this report on another domain, it was illegally stolen and republished in violation of US & international trademark and copyright legislation. The correct version of this report can be viewed at https://www.americanbankingnews.com/2018/01/18/assura-agr-stock-rating-reaffirmed-by-jefferies-group.html.

About Assura

Assura plc is a United Kingdom-based healthcare real estate investment trust (REIT). The Company is a primary care property investor and developer. The Company develops, invests and manages a portfolio of primary care medical centers across the United Kingdom. The Company’s property portfolio includes Alwoodley Medical Centre, Leeds; Fleetwood Health and Wellbeing Centre, Fleetwood; Frome Medical Practice, Frome; Claremont Medical Centre, Surbiton; Elbury Moor Medical Centre; Grey Gable Surgery; Trellech Surgery; Bewdley Medical Centre; Malmesbury Primary Care Centre, Malmesbury, and Urmston Group Practice, Urmston.

Receive News & Ratings for Assura Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Assura and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply